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Hepatitis C virus (HCV) core protein has been shown to interact with the death domain (DD) of tumor necrosis factor
receptor-1 (TNFR1). In this study, we further examined the interaction of the core protein with the signaling molecules of
TNFR1, including FADD, TRADD, and TRAF2, in a human embryonic kidney cell line, HEK-293, that overexpresses the HCV
core protein. This core protein-expressing cell line exhibited enhanced sensitivity to TNF-induced apoptosis. By in vitro
binding and in vivo coimmunoprecipitation assays, we showed that the HCV core protein interacted with the DD of FADD and
enhanced apoptosis induced by FADD overexpression. This enhancement could be blocked by a dominant-negative mutant
of FADD. In contrast, the core protein did not directly interact with the DD of TRADD, but could disrupt the binding of TRADD
to TNFR1. TRAF2 recruitment to the TNFR1 signaling complex was also disrupted by the core protein. Correspondingly,
TRAF2-dependent activation of the protein kinase JNK was suppressed in the core protein-expressing cells. However, NFkB
activation by TNF was not significantly altered by the HCV core protein, suggesting the existence of TRAF2-independent
pathways for NFkB activation. These results combined indicate that the HCV core protein sensitizes cells to TNF-induced
apoptosis primarily by facilitating FADD recruitment to TNFR1. The inhibition of JNK activation by the HCV core protein may
also contribute to the increased propensity of cells for apoptosis. These results, in comparison with other published studies,
suggest that the effects of the HCV core protein and their underlying mechanisms vary significantly among cells of different
origins. © 2001 Academic PressT
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Hepatitis C virus (HCV) is the major causative agent of
non-A, non-B hepatitis (Alter et al., 1992; Choo et al.,
1989). The virus encodes three structural proteins (core,
E1, and E2 proteins) and six nonstructural proteins from
a 9.5-kb positive-sense, single-stranded RNA genome
(Matsuura et al., 1994). Among the structural proteins, the
ore protein not only constitutes the viral nucleocapsid,
ut also carries several presumptive regulatory func-
ions. For example: It either enhances or suppresses
arious viral or cellular promoters (Ray et al., 1995; Shih
t al., 1995); it binds to several putative transcription
actors, including hnRNP K and RNA helicase, and po-
entially affects the expression of cellular genes (Hsieh
t al., 1998; You et al., 1999b); and it has transforming
ctivities (Ray et al., 1996, 2000), but also activates or
uppresses the p53 gene (Lu et al., 1999; Otsuka et al.,
000; Ray et al., 1997). It also binds to at least two
ytokine receptors, i.e., lymphotoxin b receptor (Chen et
al., 1997; Matsumoto et al., 1997) and tumor necrosis
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178factor receptor-1 (TNFR1) (Zhu et al., 1998). Correspond-
ingly, the core protein may enhance the apoptosis in-
duced by ligands of the TNF family, e.g., lymphotoxin ab
complex, TNF, and Fas ligand (Chen et al., 1997; Ruggieri
et al., 1997; Zhu et al., 1998). However, the suppression of
cytokine-induced apoptosis by the core protein has also
been reported (Marusawa et al., 1999; Ray et al., 1998a).
he binding of the core protein to TNFR1 is particularly
ntriguing, because TNF is known to play an important
ole in liver pathology.
In our previous study, we showed that the core protein
nhanced TNF-induced apoptosis in several mouse and
uman cell lines (Zhu et al., 1998); however, the mecha-
ism of enhancement was not known. Crystallographic
tudies suggest that activation of TNFR1 occurs by li-
and-mediated oligomerization through the death do-
ain (DD) (Banner et al., 1993). Extensive studies have
hown that the DD is a protein–protein interacting do-
ain, responsible for the recruitment of cellular signal
ransducers to the receptors during receptor engage-
ent (Schulze-Osthoff et al., 1998). The DD is also
resent in some of the TNFR-associated signal transduc-
ion molecules, such as TNFR-associated death domain
rotein (TRADD) and Fas-associated death domain pro-
ein (FADD) (Hsu et al., 1996). Upon oligomerization of
NFR, TRADD is recruited, which subsequently recruits
ADD, to the receptor. FADD (Boldin et al., 1995; Chin-
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179HCV CORE PROTEIN AND SIGNALING MOLECULES OF TNFRnaiyan et al., 1995) then directly interacts with the apop-
totic proteases (Boldin et al., 1996; Muzio et al., 1996) and
riggers apoptosis. However, recent studies suggested that
NFR may function as a preformed complex through a
re-ligand-binding assembly domain (Chan et al., 2000),
nstead of the ligand-mediated oligomerization through the
D (Banner et al., 1993). It is known that FADD activates
caspases, such as CPP32, which are the ultimate execu-
tors of apoptosis (Fernandes-Alnemri and Alnemri, 1994;
Nicholson et al., 1995; Tewari and Dixit, 1995). On the other
hand, the N-terminus of TRADD also recruits (TRAF2)
TNFR-associated factor 2 through its TRAF domain (Hsu et
al., 1996), which then activates a c-jun N-terminal kinase
(JNK) and nuclear factor-k (NFkB) (Yeh et al., 1997). How-
ever, several different studies have suggested that NFkB
activation can also be mediated by pathways that are in-
dependent of TRAF2 (Shi and Kehrl, 1997). Both JNK and
NFkB have been shown to be affected by the HCV core
protein (Marusawa et al., 1999; Ray et al., 1998b; You et al.,
1999a); however, in some cases, the activation status of
these molecules did not correlate with the enhancement or
suppression of the apoptosis of the cells.
In this study, using a human embryonic kidney 293
(HEK-293) cell line, which has a high transfection effi-
ciency, we confirmed our previous finding (Zhu et al.,
1998) that the core protein could sensitize cells to TNF-
induced apoptosis. We showed that the core protein
interacts not only with TNFR1 but also with the death
domain of FADD, but not that of TRADD. The FADD
pathway was further demonstrated to be the main path-
way for the sensitization of the core protein-expressing
cells to TNF. On the other hand, the core protein dis-
rupted the recruitment of TRADD and TRAF2 to TNFR1.
Correspondingly, TNF-induced activation of JNK was
suppressed, which may also contribute to TNF sensitiv-
ity. However, TNF-induced NFkB activation was not af-
ected by the core protein, suggesting the presence of
RAF2-independent NFkB activation. We conclude that
HCV core protein sensitizes cells to TNF-induced apop-
tosis mainly by facilitating recruitment of FADD, which
leads to apoptosis. Thus, the core protein has multiple
effects on the signal transduction pathways of TNFR.
RESULTS
HCV core protein sensitizes HEK-293 cells
to TNF-induced cell death
We previously demonstrated that the HCV core protein
could sensitize three different cell lines, including murine
BC10ME cells and human HeLa and HepG2 cells, to
TNF-induced apoptosis in the presence of a transcription
inhibitor actinomycin D (Zhu et al., 1998). However, these
cells have a low transfection efficiency and, thus, are not
easily amenable to the studies of the signal transduction
pathways of TNFR. Therefore, we attempted to establish
core protein-expressing human embryonic kidney 293 ccell lines, which are known to be efficient for transfec-
tion. HEK-293 cells were transfected with a plasmid en-
coding the full-length HCV core protein or the empty
vector plasmid and selected with G418. Resistant cell
colonies were pooled and designated 293/CORE and
293/EF, respectively. The cells were examined for core
protein expression by immunoblotting. The core protein
was detected in 293/CORE cells by immunoblotting, as
shown in the inset of Fig. 1. Furthermore, all cell lines
express comparable levels of TNFR, as determined by
Western blotting of the total cell lysates (data not shown).
To test the sensitivity of these cells to TNF, cells were
treated with human TNF-a in the presence of actinomy-
in D, and the percentage of cell death was determined
y MTT assay. Similar to the core-expressing BC10ME,
eLa, and HepG2 cells (Zhu et al., 1998), the core pro-
ein-expressing 293/CORE cells were more sensitive to
NF-induced apoptosis than the control 293/EF cells.
he difference in TNF sensitivity between the two cell
ools was approximately three- to fourfold in a wide
ange of TNF concentrations (Fig. 1).
CV core protein interacts with FADD but not TRADD
To understand the mechanism of the core protein-
nhanced sensitivity to TNF in 293 cells, we examined
he status of various signal transduction pathways of
NFR in these cells. We have previously shown that the
ore protein binds to the death domain of the TNFR1
ytoplasmic region (Zhu et al., 1998). To study how the
FIG. 1. Effects of HCV core protein expression on the sensitivity of
293 cells to TNF-induced cell death. Stably transformed cell pools of
293/EF (control) and 293/CORE were treated with various concentra-
tions of human TNF (hTNF) as indicated. Cells were subjected to the
MTT assay. The percentage of cell death was calculated based on
OD560 values from three independent experiments. The inset shows the
immunoblotting of the core protein in these two cell pools.ore protein altered the signal transduction of TNFR1, we
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180 ZHU, WARE, AND LAIfirst looked at the possibility that the HCV core protein
may also bind TRADD or FADD, both of which have a
death domain and play critical roles in TNFR1-mediated
apoptosis (Hsu et al., 1996).
We used the glutathionine S-transferase (GST) pull-down
assay to determine whether the core protein can interact
directly with TRADD or FADD. Several GST-fusion proteins
were tested for their ability to bind the 35S-labeled, in vitro
translated TRADD. As expected, TRADD binds to the cyto-
plasmic region of TNFR1 fused to GST, but not to GST
alone. Furthermore, TRADD did not bind to the GST-CORE
protein (Fig. 2A), indicating that there is no direct interaction
between the core protein and TRADD. On the other hand,
the in vitro translated, 35S-labeled HCV core protein bound
he GST-FADD fusion protein containing aa 80 to 205, which
ncludes the death domain, but not the GST-CD40 fusion
rotein (Fig. 2B). The core protein also did not bind GST
lone. These results indicated that the HCV core protein
nteracts with FADD, but not with TRADD. The N-terminal
ydrophilic portion (aa 1–153) of the core protein is suffi-
ient for the binding to FADD (see below), similar to that
equired for the binding to TNFR (Zhu et al., 1998). There-
ore, the HCV core protein binds not only to TNFR1 as
reviously reported (Zhu et al., 1998), but also to one of its
ignal transduction molecules, FADD. The binding of the
ore protein to TNFR1 was approximately threefold better
han the binding between the core protein and FADD,
ased on the percentage of the 35S-labeled core protein
bound to the comparable amounts of the respective GST
fusion proteins.
The HCV core protein interacts with FADD and
potentiates FADD-induced apoptosis in 293 cells
To determine whether the core protein and FADD
FIG. 2. In vitro GST binding assay of HCV core protein with TRADD
and FADD. (A) 35S-labeled in vitro translated TRADD (2 ml) was incu-
ated with 2 mg of GST fusion proteins that express the cytoplasmic
egion of TNFR1, the entire core protein, or the GST protein alone. (B)
35S-labeled in vitro translated core protein (2 ml) was incubated with 2
mg of GST fusion proteins that express the cytoplasmic region of CD40
or a truncated form of FADD (80–205). The bound proteins were sep-
arated by SDS–PAGE and detected by autoradiography.could interact with each other in the cells, we performedcoimmunoprecipitation experiments. 293/EF and 293/
CORE cells were transfected with a plasmid expressing
an N-terminal Flag-tagged FADD. Anti-Flag-conjugated
beads were used to immunoprecipitate FADD, and the
complex was separated by SDS–PAGE followed by im-
munoblotting for core protein. As shown in Fig. 3, the
core protein was coprecipitated with the overexpressed
FADD from the core protein-expressing 293 cells (lane 3,
Fig. 3). As a control, anti-Flag-conjugated beads did not
precipitate the core protein in the absence of Flag-FADD
(lane 1, Fig. 3). These results indicated that the HCV core
protein could interact with FADD in 293 cells.
To test the possibility that the enhancement of sensi-
tivity to TNF-induced apoptosis by the core protein is
mediated through the FADD signaling pathway, we over-
expressed TNFR1 and/or FADD in 293 cells in the pres-
ence or absence of the core protein. Consistent with the
previous report (Hsu et al., 1996), overexpression of ei-
ther TNFR1 or FADD alone led to significant apoptosis in
293 cells stably transformed with either the core-ex-
pressing plasmid or the vector plasmid (Fig. 4). The core
protein-expressing 293/CORE cells showed a slightly
higher degree of apoptosis over the 293/EF cells, as
determined by the number of dead cells (rounded and
blebbing) and the number of remaining viable cells (Fig.
4, panels C and E versus panels D and F). The most
significant difference between the two cell pools, how-
ever, was observed when the cells were cotransfected
with both TNFR1 and FADD. In this case, the cells ex-
pressing the core protein (293/CORE) (panel H) had a
significantly more pronounced apoptosis than the 293/EF
cells (panel G). When a dominant-negative FADD (80–
205) was cotransfected with TNFR1, the TNFR-induced
apoptosis was reduced in both 293/EF and 293/CORE
cells and there was no significant difference between the
two cell pools. This result confirms the previous reports
that TNFR1-mediated apoptosis is mediated primarily
through FADD (Chinnaiyan et al., 1996; Hsu et al., 1996;
Wajant et al., 1998; Wallach, 1997). These results also
FIG. 3. In vivo interaction between HCV core protein and FADD.
Approximately 5 3 106 cells each of 293/EF (EF) or 293/CORE (CORE)
were transfected with pKR-Flag-FADD. Cell lysates were incubated
with 0.5 ml of anti-Flag beads. After extensive washes, the captured
proteins were resuspended in protein loading buffer and immunoblot-
ted for core protein. Lysates without immunoprecipitation (Pre-IP) were
included as positive controls. Lysates without transfection of pKR-Flag-
FADD (lane 1) were included as negative controls.
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181HCV CORE PROTEIN AND SIGNALING MOLECULES OF TNFRshowed that the core protein-induced sensitization of
cells to TNFR1-mediated apoptosis could be blocked by
the dominant-negative mutant of FADD. Therefore, the
apoptosis-enhancing effect of the core protein was me-
diated mainly through the FADD pathway. These data
established a direct role of the core protein in enhancing
FADD-induced apoptosis in TNFR1 signaling.
We also examined the CPP32 caspase activity induced
by TNF in the cells expressing the HCV core protein. The
results showed that the CPP32 caspase activity was
higher in the core-expressing cells than in the vector-
transfected cells after TNF treatment (Fig. 5). This result
is consistent with the finding that TNF induced a higher
degree of apoptosis in the cells expressing the core
protein.
In all of the experiments, the transfection efficiency
was determined by cotransfection of a plasmid express-
ing the green fluorescent protein (GFP), which showed
that an average of 80–90% of cells expressed GFP at 20 h
posttransfection (data not shown). All these results sup-
port the hypothesis that HCV core protein enhanced
TNF-induced apoptosis mainly by facilitating the recruit-
ment and signaling of FADD.
HCV core protein disrupts the TNFR1–TRADD–TRAF2
complex
We next examined whether the core protein also af-
fected other signaling pathways of TNFR, such as
TRADD–TRAF2-mediated pathways. Since both core pro-
FIG. 4. Effects of HCV core protein on apoptosis induced by overex-
ression of TNFR1 and FADD. Approximately 5 3 105 cells each of
293/EF and 293/CORE were transfected with combinations of 1.5 mg of
pcDNA/TNFR1 (TNFR1), pRK-Flag-FADD (FADD), or FADD (80–205) as
indicated. Cells were examined under light microscopy at 40 h post-
transfection. The results shown are representative of three separate
experiments. The numbers of viable cells were counted under the
microscope and presented as percentages relative to the untreated
cells (A and B).tein and TRADD bind to the death domain of TNFR1(Tartaglia et al., 1993; Zhu et al., 1998), and there is no
direct in vitro interaction between the core protein and
TRADD (Fig. 2), it is conceivable that the binding of the
core protein may disrupt TRADD signaling. Therefore, we
examined whether the core protein would affect the
potential formation of a TNFR1–TRADD–TRAF2 complex,
which mediates TNFR signaling. To examine this possi-
bility, constructs that express a GST protein fused to the
TNFR1 cytoplasmic region with (GST/DD) or without
(GST/NDD) the death domain were separately cotrans-
fected with the plasmid expressing a truncated core
protein (aa 1–153) into 293 cells. The truncated core
protein was used in this study because its expression
level was higher than that of the full-length core protein
(data not shown). We have previously shown that the
truncated core protein (aa 1–153) was sufficient for in-
teraction with TNFR1 (Zhu et al., 1998). Cytoplasmic ex-
tracts from the transfected cells were used for the GST
pull-down assay and examined by immunoblotting for
TRADD, TRAF2, the core protein, and GST fusion pro-
teins. As shown in Fig. 6, a GST fusion protein containing
the death domain of TNFR1 was expressed in a much
smaller amount than that lacking the death domain (Fig.
6, lanes 1–4); nevertheless, both of them were pulled
down efficiently by the glutathione beads (Fig. 6, lanes
5–8). The core protein was detected in the GST pull-
down fractions only in the cells expressing GST/DD but
not GST/NDD (lanes 6 and 8), confirming the previous
finding that the core protein binds to the death domain of
TNFR1 (Zhu et al., 1998). It is noteworthy that only a small
fraction of the total core protein in the cells was pulled
down by GST/DD, indicating that the core protein was
much more abundantly expressed than GST/DD. In the
absence of the core protein, the death domain, but not
the non-death domain, of TNFR1 pulled down a signifi-
cant amount of TRADD (Fig. 6, lanes 5 and 7). This
confirmed the previous report that TRADD interacted
directly with TNFR1 in vivo (Hsu et al., 1996). However, in
the presence of the core protein, only a trace amount of
TRADD was pulled down (lane 8), suggesting that the
FIG. 5. CPP32 caspase assays. Approximately 2 3 106 293 perma-
ent cells were treated or untreated with human TNF (60 ng/ml) for 16 h
n the presence of actinomycin D (1 mg/ml). Equal amounts of cell
lysates were subjected to CPP32 assay (Clontech) and the CPP32
activity was determined by reading at OD400. The data are the averages
of two experiments.
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182 ZHU, WARE, AND LAIinteraction between TRADD and TNFR1 was disrupted.
As expected, TRAF2 was also pulled down by GST/DD,
but not by GST/NDD (lanes 5 and 7), consistent with the
report that, upon interaction with TNFR1, TRADD could
recruit TRAF2 (Hsu et al., 1996). In the presence of the
core protein, TRAF2 was not precipitated by GST/DD
(lane 8), suggesting that the disruption of the TRADD–
TNFR1 interaction by the core protein also resulted in
reduced recruitment of TRAF2. These results suggested
that the core protein disrupted the formation of a TNFR1–
TRADD–TRAF2 complex by competing with the binding
of TRADD to the death domain of TNFR1.
HCV core protein disrupts TNF-induced JNK
activation but not NFkB activation
TRAF2 has been suggested as the key mediator for
NFkB and JNK activation in TNF induction (Liu et al.,
996; Malinin et al., 1997). The finding that the core
rotein disrupted the recruitment of TRAF2 in TNF induc-
ion led us to investigate whether NFkB and JNK signal-
ing were impaired in the presence of the core protein.
NFkB activation was assayed by the nuclear transloca-
ion of Rel A upon TNF stimulation. As we have shown in
ur previous work, the core protein suppressed NFkB
activation only in a mouse cell line (BC10ME), but not in
two human cell lines tested (HeLa and HepG2). Results
with 293 cells showed that the TNF treatment resulted in
the nuclear translocation of roughly the same amount of
Rel A in both the core protein-expressing cells (293/
CORE) and control (EF) cells (Fig. 7A). This result sug-
gests that the expression of the core protein did not
result in significant suppression of NFkB activation. In
contrast, the activation of JNK (as assayed by the phos-
phorylation of c-jun) by TNF in the core-expressing cells
FIG. 6. The core protein disrupts the TNFR1–TRADD–TRAF2 complex
in vivo. Approximately 5 3 106 cells of 293/CORE or 293/EF cells
nfected with vTF-7 recombinant vaccinia virus (m.o.i., 1) for 2 h, fol-
owed by cotransfection with 5 mg each of plasmids encoding the HCV
ore protein (aa 1–153) and GST/DD or GST/NDD of TNFR1 cytoplas-
ic regions. Cytoplasmic extract (60 mg) from each sample was incu-
bated with GST beads and the captured proteins were resolved by
SDS–PAGE followed by immunoblots for GST fusion protein, HCV core
protein, TRADD, and TRAF2.was much weaker and had a slightly delayed kinetics scompared to the control (EF) cells (Fig. 7B). Quantitation
of the phosphorylated c-jun indicated an approximately
twofold reduction in the activation of JNK in the cells
expressing the core protein. Western blotting of the JNK1
using anti-JNK1 antibody showed that the amounts of
JNK1 proteins did not vary in any of the samples (Fig. 7B).
The inhibition of JNK activation may further contribute to
the sensitivity of cells to TNF, although the role of JNK in
TNF signaling may depend on cell conditions. There
have been contradictory results regarding whether JNK
activation is proapoptosis, antiapoptosis, or neither (Liu
et al., 1996) (see Discussion).
DISCUSSION
Previous studies from our laboratory have shown that
expression of the HCV core protein in several human and
mouse cell lines enhanced TNF-induced apoptosis,
probably as a result of the binding of the core protein to
TNFR1 (Zhu et al., 1998). However, the mechanism of the
nhanced TNF sensitivity was not previously known, and
t may differ among different cell types. For example,
NF-induced NFkB activation was suppressed in the
ore protein-expressing mouse cells (BC10ME) but not
he human cells (HeLa and HepG2), although all three
ell lines were similarly sensitized to TNF by the HCV
ore protein (Zhu et al., 1998). By using a core protein-
xpressing 293 cell system, which allows efficient trans-
FIG. 7. Effects of HCV core protein on TNF-induced JNK and NFkB
ctivation. (A) Assays for TNF-induced NFkB activation. Cytoplasmic
xtracts (CE) and nuclear extracts (NE) (60 mg) from 293/EF (EF) and
293/CORE (CORE) cells, either treated with TNF (1) or untreated (2),
were analyzed by immunoblotting for Rel A. (B) Assays for TNF-induced
JNK activation. Approximately 1 3 106 cells were treated with 10 ng/ml
of TNF. Cell lysates were harvested at different time points and incu-
bated with 0.3 mg of goat anti-JNK1 antibody at 4°C for 2 h. Protein
–Sepharose (20 ml) was added and incubated for an additional 1 h.
he beads were washed and adjusted to 30 ml in reaction buffer. The
n vitro kinase assay was performed for 20 min at 30°C. The phosphor-
lation of c-jun was determined by SDS–PAGE followed by autoradiog-
aphy (upper panel) and quantified using the Ambis PhosphorImaging
ystem. The lower panel shows the immunoblotting using the JNK1-
pecific antibody.
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183HCV CORE PROTEIN AND SIGNALING MOLECULES OF TNFRfection, we were able to elucidate in this study the signal
transduction pathways that led to the enhanced TNF
sensitivity. Two basic mechanisms account for this effect:
(1) Core protein binds to FADD and TNFR and thus
recruits FADD to TNFR. The enhanced apoptosis medi-
ated by the core protein was most evident when both
TNFR and FADD were coexpressed, and this effect was
almost completely blocked by a dominant-negative mu-
tant of FADD. Therefore, FADD is probably the major
mediator of the enhanced TNF sensitivity caused by the
core protein. (2) The TRADD–TRAF2 signal transduction
pathway is blocked, probably because the core protein
occupies the TRADD-binding site on the TNFR. As a
result, JNK activation is suppressed, which may contrib-
ute to apoptosis, although the role of JNK in apoptosis
has been controversial in the literature. In contrast to
mouse cells, in which NFkB activation was inhibited by
the expression of the HCV core protein (Zhu et al., 1998),
the TNF-induced NFkB activation was not inhibited by
the core protein in 293 cells, suggesting that NFkB can
e activated by a TRAF2-independent pathway in human
ells and that the core protein does not affect this path-
ay. These results combined thus explain the mecha-
ism of the core protein-induced enhancement of TNF
ensitivity in our cell lines.
The TRADD protein is like a two-edged sword, which
eads to two opposing outcomes of TNFR1-mediated
ignaling. On the one hand, TRADD recruits FADD, which
inds to caspase 8 and triggers a cascade of caspase
ctivation, leading to apoptosis. On the other hand,
RADD also recruits TRAF2, which activates two distinct
athways. One involves the protein kinase NIK (Malinin
t al., 1997), which leads to NFkB activation, while the
ther is independent of NIK (Natoli et al., 1997b), which
ctivates JNKs stress-activated protein kinases (SAPKs)
Liu et al., 1996) and, subsequently, several transcription
actors, including c-jun (Reinhard et al., 1997). It is known
hat NFkB (Rel A) activation protects cells against apo-
ptosis induced by TNF (Van Antwerp et al., 1996). We did
observe suppression by the core protein of Rel-A activa-
tion in a mouse cell line, but not in any of the human cell
lines examined, including HepG2, HeLa, and 293 cells
(Zhu et al., 1998). This finding is not surprising, since
TRAF2-independent NFkB activation pathways do exist
in the cells, as suggested by the lack of suppression of
NFkB activation in TRAF2 knockout mice (Yeh et al.,
997). On the other hand, TRAF2 is the major mediator of
NK activation (Liu et al., 1996; Natoli et al., 1997a; Shi
nd Kehrl, 1997). Consistently, we observed the suppres-
ion of JNK activation in the core protein-expressing
ells. The role of JNK activation in TNFR signal transduc-
ion is still controversial; overexpression of TRAF2 does
ot stimulate apoptosis induced by TNF, and it is not
equired for TNF-induced apoptosis (Natoli et al., 1998).
owever, it has been reported that the JNK pathway may
rotect cells against Fas-mediated apoptosis (Nishina et al., 1997); thus, the suppression of TRAF2 by the core
rotein may make cells proapoptotic. In summary, the
ecruitment of FADD to TNFR1 by the core protein ap-
ears to be the primary mechanism of the enhanced
ensitivity to TNF by the HCV core protein. Nevertheless,
he TRAF2–JNK pathway may also be involved.
Why then did different laboratories observe different
ffects of the HCV core protein on the cellular sensitivity
o cytokines of the TNF family? We have consistently
bserved enhanced sensitivity to TNF in four different
ell lines expressing the core protein, although the
echanism of enhancement varied from cell to cell. This
nhanced sensitivity was also extended to other TNF-
elated cytokines (lymphotoxin ab and Fas) in other cell
lines (Chen et al., 1997; Ruggieri et al., 1997). On the
ther hand, at least two laboratories observed a reduc-
ion of TNF sensitivity by the HCV core protein (Maru-
awa et al., 1999; Ray et al., 1998a), and another cell line
id not show altered sensitivity to TNF (You et al., 1999a).
ifferent cell lines also showed significantly different
ffects of the HCV core protein on signal transducers
FkB and JNK, the intracellular levels of which did not
orrelate well with the extent of apoptosis. For example,
he expression of HCV core protein in a breast cancer
ell line, MCF7, which does not contain caspase 3 (Jan-
cke et al., 1998), rendered the cells more resistant to
NF-induced apoptosis (Ray et al., 1998a), and yet NFkB
activation was suppressed and JNK was constitutively
activated in these cells (Shrivastava et al., 1998). These
differences may be attributable to the differences in the
viral core protein sequence used by different laborato-
ries and in the cell culture conditions. Different HCV
isolates showed significant sequence differences, and
the core protein also is processed to different degrees in
different cell lines (Hussy et al., 1996; Liu et al., 1996; Lo
et al., 1994). Furthermore, the HCV core protein can
enhance or suppress the expression of certain cellular
genes (Ray et al., 1995) and interact with hnRNP K (Hsieh
et al., 1998), RNA helicase (You et al., 1999b), 14-3-3
protein (Aoki et al., 2000), and bZIP protein (Jin et al.,
2000), all of which can conceivably modulate the effects
of the core protein on the TNF response. The core pro-
tein also can constitutively induce apoptosis in the ab-
sence of TNF (Honda et al., 2000). Therefore, the sensi-
tization of cells to TNF-induced apoptosis by core protein
is likely modulated by many factors, and not merely
determined by the NFkB or JNK levels. Thus far, we have
hown that the core protein binds to the death domains
f TNFR1 and FADD, but not of TRADD. Furthermore,
RADD binds both TNFR1 and FADD via the death do-
ain interaction; however, TNFR1 does not interact with
ADD directly (Hsu et al., 1996), suggesting that there are
ifferences among the various death domains. This se-
ectivity potentially allows the core protein to enhance
poptosis through certain signaling pathways without
ffecting others. The relative abundance of the different
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184 ZHU, WARE, AND LAIsignal transducers in different cells may contribute to the
differences in the overall effects of the HCV core protein.
Although TNF plays a key role in the proliferative
response in normal liver (Bradham et al., 1998; Diehl et
l., 1994), it has a direct cytotoxic role in injured or
iseased liver. For example, in acute liver injury, TNF
riggers apoptosis of hepatocytes and plays a central
ole in pathogenesis. In the endotoxin/galactosamine
odel, lipopolysaccharide induced a hepatocyte inflam-
atory response, resulting in an increase in TNF level,
hich preceded liver failure. Moreover, TNFR1 was in-
ispensable for the induction of liver damage in this
odel (Leist et al., 1995; Pfeffer et al., 1993). TNF is also
elieved to contribute to liver cell damage in a con-
anavalin model (Gantner et al., 1995). A direct cytotoxic
ole of TNF in human hepatocytes was established clin-
cally during chemotherapy (Bradham et al., 1998). TNF
concentration was significantly higher in patients who
did not survive an episode of acute alcoholic hepatitis
(Bird et al., 1990). Both hepatitis B and C viruses induce
TNF expression in human liver and human hepatoma cell
lines (Gonzalez-Amaro et al., 1994). In summary, there is
a consistent pattern of enhanced TNF signaling in in-
jured or damaged liver, which is linked directly to hepa-
tocytotoxicity. Sensitization of cells to TNF-induced apop-
tosis by HCV core protein thus has direct clinical rele-
vance. In addition, an elevated TNF level in HCV-infected
patients would make the core-expressing cells even
more vulnerable. It is very likely that in the case of
hepatitis C infection, HCV pathogenesis is a combined
result of enhanced TNF signaling by HCV core protein
and elevated TNF concentrations in patients.
MATERIALS AND METHODS
Cell lines
The 293 cell line, which was obtained from the Amer-
ican Tissue Culture Collection (ATCC), is a human em-
bryonic kidney cell line transformed with adenovirus E1A
protein. Cells were grown in Dulbecco’s modified Eagle
medium (DMEM; Irvine Scientific) supplemented with
10% fetal bovine serum (Gemini Bioproducts, Inc.). The
293 cells expressing the core protein were obtained by
transfection with pcDEF/core (Zhu et al., 1998), which
expresses the full-length core protein of the HCV Taiwan
strain (Chen et al., 1992) under the translation elongation
factor-1 promoter (Kim et al., 1990). Cells were selected
in the presence of 0.6 mg/ml of G418 (Life Technologies)
as described previously (Zhu et al., 1998). The G418-
resistant cells were pooled and designated 293/CORE.
As a control, cells transformed with the empty vector
pcDEF were similarly obtained and named 293/EF.
Expression vectors
pEGFP-C1, which can express the green fluorescent
protein in mammalian cells under the cytomegalovirus w(CMV) promoter, was purchased from Clontech Labora-
tories, Inc. pcDNA/TNFR1 was constructed with the en-
tire TNFR1 gene being inserted in the BamH1 and EcoR1
sites of the pcDNA3 vector (Clontech) under the CMV
promoter. pRK-Flag-mFADD and pRK-myc-TRADD, which
express Flag-tagged FADD and myc-tagged TRADD pro-
teins, respectively, were kindly provided by Dr. D. Goed-
del (Hsu et al., 1996). FADD (80–205), a deletion mutant of
FADD containing amino acids 80–205, was made by PCR
and cloned into the BamHI and EcoRI sites of pcDNA3
under T7 and CMV promoters. GST/DD was constructed
with glutathione S-transferase fused to the fragment of
TNFR1 that contains the death domain (aa 340–426) and
inserted into pBluescript vector (Pharmacia) at the
BamHI site. GST/NDD was constructed similarly by in-
serting GST fused to the non-death domain cytoplasmic
tail of TNFR (aa 205–308) into pBlueScript at the BamHI
site. The resulting plasmids GST/DD and GST/NDD can
express the respective GST fusion proteins under the T7
promoter in mammalian cells when coinfected with the
recombinant vaccinia virus vT-7 that expresses the T7
RNA polymerase (Frederick et al., 1987).
MTT assay
Approximately 4 3 104 cells were treated with human
NF (R&D, Inc.) at various concentrations in the pres-
nce of 1 mg actinomycin D per milliliter for 16 h and
stained by 1 mg of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT; Research Organics, Inc.)
for 3 h as described previously (Zhu et al., 1998). The
ercentage of cell death was calculated based on the
D560 according to the following formula: percentage of
ell death 5 100 2 OD560 of TNF-treated sample/OD560 of
ntreated sample). All experiments were performed in
riplicates in 96-well plates. The standard deviation was
alculated from data of three independently performed
xperiments.
n vitro GST-binding assay
GST fusion proteins were expressed in Escherichia
oli BL21(DE) (Novagen) and purified with glutathione–
epharose 4B beads as specified by the manufacturer
Pharmacia Biotech). GST-TNFR1 and GST-CD40 were
ST fusion proteins that contained the entire cytoplas-
ic region of the corresponding receptors (Zhu et al.,
998). GST-CORE was a GST fusion protein that ex-
ressed the entire HCV core protein. GST-FADD was a
ST fusion protein that expressed amino acids 80–205 of
ADD, which lacks the ligand-binding domain (Hsu et al.,
996). 35S-labeled in vitro translated protein (2 ml) was
incubated with approximately 2 mg of GST fusion pro-
eins attached to Sepharose beads at 4°C for 2 h in
inding buffer [40 mM HEPES (pH 7.5), 100 mM KCl, 0.1%
onidet P-40, 20 mM 2-mercaptoethanol)]. The beads
ere subsequently washed four times and were ana-
1m
w
o
w
l
(
r
p
a
t
J
T
T
N
m
d
C
3
3
l
S
p
J
N
a
i
m
185HCV CORE PROTEIN AND SIGNALING MOLECULES OF TNFRlyzed by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) followed by autoradiography.
Coimmunoprecipitation and in vivo GST-binding assay
Cytoplasmic extracts were prepared as previously re-
ported (Zhu et al., 1998). Briefly, cell pellets were resus-
pended in 100 ml buffer A [10 mM HEPES–KOH (pH 7.8),
0 mM KCl, 1.5 mM MgCl2, 20% glycerol, 0.5 mM dithio-
threitol) and incubated on ice for 15 min. The lysate was
brought to 0.5% of Nonidet P-40 before centrifugation at
8000 rpm for 5 min at 4°C in a microfuge. The superna-
tant (cytoplasmic extract) was collected, and protein con-
centration was measured by Bio-Rad protein assay.
For in vivo coimmunoprecipitation assays, approxi-
mately 5 3 106 cells of 293/EF or 293/CORE cells were
transfected with 5 mg of pRK-Flag-FADD by the DOTAP
ethod (Boehringer Mannheim). Cytoplasmic extract
as prepared 48 h after transfection. A quantity of 0.5 ml
f Flag beads (VWR Scientific Products) was incubated
ith 40 ml of cytoplasmic extract in a total volume of 400
ml reaction buffer [40 mM HEPES (pH 7.5), 100 mM KCl,
0.5% Nonidet P-40, 20 mM 2-mercaptoethanol). After five
washings with the reaction buffer, the Flag beads were
resuspended in protein loading buffer and analyzed by
immunoblot with anti-core protein antibody.
Approximately 5 3 106 permanent 293 cells were in-
fected with vT-7 vaccinia virus (Fuerst et al., 1986) (m.o.i.
5 1) for 2 h, followed by transfection with 5 mg of
plasmids encoding the HCV core protein (aa 1–153) and
those encoding GST/DD or GST/NDD of the TNFR1 cy-
toplasmic regions, all of which are under the T7 pro-
moter. The cytoplasmic extract was prepared 14 h after
transfection. Total protein (60 mg) for each sample was
loaded on 12.5% SDS–PAGE. Immunoblots were per-
formed using rabbit anti-core protein antibody, rabbit
anti-GST antibody (Santa Cruz Biotechnology, Inc.), goat
anti-TRADD antibody (Santa Cruz Biotechnology, Inc.), or
rabbit anti-TRAF2 antibody (Santa Cruz Biotechnology,
Inc.).
Overexpression of TNFR1 and FADD
Approximately 5 3 105 permanent 293/EF and 293/
CORE cells were transfected with combinations of 1.5 mg
of pcDNA/TNFR1 or pRK-Flag-FADD or FADD (80–205).
pEGFP-C1 (0.2 mg) was cotransfected as an indicator of
transfection efficiency, which was determined at 20 h
posttransfection. The vector plasmid pcDNA3 was used
to adjust all transfections to the same amount of total
DNA. Cells were examined by light microscopy at 40 h
posttransfection.
CPP32 caspase assay
Approximately 2 3 106 293 permanent cells were
treated with human TNF (60 ng/ml) for 16 h in the pres-
ence of actinomycin D (1 mg/ml). Cells were washed andysed according to the manufacturer’s instructions
ApoAlert, CPP32/Caspase-3 assay kits, Clontech Labo-
atories, Inc.). Cell lysates were normalized with Bio-Rad
rotein assay first before they were subjected to CPP32
ssay. The CPP32 activity was proportionally reflected by
he optical density at a wavelength of 400 nm.
NK kinase assay
Approximately 106 cells were treated with 10 ng/ml of
NF for 5 to 30 min. Cells were then lysed with 400 ml of
riton lysis buffer [20 mM Tris–HCl (pH 7.5), 137 mM
aCl, 1 mM phenylmethylsulfonyl fluoride, 5 mM EDTA, 2
M EGTA, 1 mM Na3VO4, 25 mM b-glycerophosphate,
50 mM NaF, 10 mM sodium pyrophosphate, 15% (v/v)
glycerol, and 1% (v/v) Triton X-100] (Yeh et al., 1997). Cell
lysates were centrifuged and the supernatant was incu-
bated with 0.3 mg of goat anti-JNK1 antibody (Santa Cruz
Biotechnology, Inc.) at 4°C for 2 h. Protein G–Sepharose
(20 ml) was added and incubated for an additional 1 h.
The beads were washed twice with Triton lysis buffer
and twice with JNK reaction buffer [25 mM HEPES (pH
7.4), 25 mM b-glycerophosphate, 25 mM MgCl2, 2 mM
ithiothreitol (DTT), and 0.1 mM Na3VO4). The final vol-
ume of the beads was adjusted to 30 ml in reaction
buffer. A quantity of 1 mg of GST-c-jun (aa 1–79) (Santa
ruz Biotechnology, Inc.), 6 ml of 100 mM ATP, 1 ml of 0.5
mCi[g32P]ATP, and 15 ml of the beads in a total volume of
0 ml of reaction buffer were incubated for 20 min at
0°C. The reactions were stopped by addition of 23
oading buffer. The kinase activity was determined by
DS–PAGE followed by autoradiography. The amount of
hosphorylated c-jun was used as the measurement of
NK activity.
FkB nuclear translocation
Cytoplasmic extract was prepared as described
bove. The pellet from centrifugation was resuspended
n buffer C [20 mM HEPES–KOH (pH 7.8), 0.42 M NaCl, 1.5
M MgCl2, 0.2 mM EDTA, 25% glycerol, 0.5 mM DTT] and
incubated at 4°C for 30 min. The mixture was spun at the
maximum speed for 10 min at 4°C in a microfuge, and
the supernatant was collected as the nuclear extract.
The protein concentration of the extract was determined
by Bio-Rad protein assay. Approximately 60 mg of total
protein from each extraction was separated by SDS–
PAGE and subjected to immunoblotting with goat anti-Rel
A antibody (Santa Cruz Biotechnology, Inc.).
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